De Ioris, Maretta; Brugieres, Laurence; Zimmermann, Arthur; Keeling, Jean; Brock, Penelope; Maibach, Rudolf; Pritchard, Jon; Shafford, Liz; Zsiros, Joszef; Czaudzerna, Piotr; Perilongo, Giorgio (2008). Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: The SIOPEL group experience. European journal of cancer, 44(4), pp. 545-550. Amsterdam: Elsevier 10.1016/j.ejca.2007.11.022
Full text not available from this repository.AIM OF THE STUDY: To investigate the characteristics of patients with hepatoblastoma and low serum alpha-fetoprotein (AFP) at diagnosis. PATIENTS AND METHODS: Inclusion of all 21 patients accrued onto SIOPEL trials, whose serum AFP was <100ng/ml at diagnosis. Slides of all 15 patients with available histological material were centrally reviewed. RESULTS: Median age: 10 months. Disease extension at diagnosis: PRETEXT group: II (3 patients), III (10 patients) and IV (8 patients). Extra-hepatic extension: 8 patients. Multifocal tumour: 8 patients. Histology at review: wholly epithelial subtype: 11/15 patients including nine with a small-cell undifferentiated histology. Outcome: only 9 patients achieved a partial response and 16 died. Median survival: 4.4 months. Two-year overall survival: 24% (confidence interval 10-45%). CONCLUSION: This study clearly identifies patients with hepatoblastoma and low serum AFP at diagnosis as a high-risk subgroup with extensive disease at diagnosis, poor response to chemotherapy and a poor outcome.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Service Sector > Institute of Pathology |
UniBE Contributor: |
Zimmermann, Arthur |
ISSN: |
0959-8049 |
ISBN: |
18166449 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:54 |
Last Modified: |
05 Dec 2022 14:16 |
Publisher DOI: |
10.1016/j.ejca.2007.11.022 |
PubMed ID: |
18166449 |
Web of Science ID: |
000255073400016 |
URI: |
https://boris.unibe.ch/id/eprint/22832 (FactScience: 37239) |